Table 1. Associations of the expression of c-Fos, Wnt2, and Fzd9 with tumor clinical stages.

	IIa stage (n = 25)	IIb/III stage (n = 29)	p-value
c-Fos expression
High(n, %)	8(32.0)	22(75.9)	p<0.01**
Low(n, %)	17(68.0)	7(24.1)
Wnt2 expression
High(n, %)	15(60.0)	27(93.1)	p<0.01**
Low(n, %)	10(40.0)	2(6.8)
Fzd9 expression
High(n, %)	7(28.0)	20(68.9)	p<0.01**
Low(n, %)	18(72.0)	9(31.1)

**With significant difference